35104900 |
Novel Likely Pathogenic Variant in the A3 Domain of von Willebrand Factor Leading to a Collagen-Binding Defect
Zieger, B,
Glonnegger, H,
Boeckelmann, D,
Fels, S,
Büchsel, M
|
Hamostaseologie |
2022 |
11583318 |
Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen
Obert, B,
Lavergne, JM,
Ribba, AS,
Meyer, D,
Loisel, I,
Cherel, G,
Girma, JP,
Juhan-Vague, I
|
Thromb Haemost |
2001 |
25051961 |
Analysis of the role of von Willebrand factor, platelet glycoprotein VI-, and α2β1-mediated collagen binding in thrombus formation
Nieswandt, B,
Stegner, D,
Mewburn, J,
Brown, C,
Vidal, B,
Lillicrap, D,
Rydz, N,
Shida, Y,
Danisment, O,
Sponagle, K,
Hegadorn, CA,
Pruss, CM,
Crawford, B
|
Blood |
2014 |
19687512 |
Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor
Gill, S,
McKinnon, TA,
Mellars, G,
Sutherland, M,
Riddell, AF,
Brown, SA,
Laffan, MA,
Gomez, K,
Millar, CM
|
Blood |
2009 |
20345715 |
Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD
Montgomery, RR,
Christopherson, PA,
Friedman, KD,
Hoffmann, RG,
Flood, VH,
Lederman, CA,
Wren, JS
|
J Thromb Haemost |
2010 |
31605304 |
Identification of a missense mutation (p.Leu1733Pro) in the A3 domain of von Willebrand factor in a family with type 2M von Willebrand disease
Ozaki, S,
Matsumoto, M,
Shibata, H,
Shigekiyo, T,
Sekimoto, E,
Yagi, H
|
Int J Hematol |
2020 |
34758185 |
Von Willebrand disease type 2M: Correlation between genotype and phenotype
Simons, A,
Brons, PPT,
Blijlevens, NMA,
Meijer, D,
Nieuwenhuizen, L,
Schols, SEM,
Krouwel, S,
Laros-van Gorkom, BAP,
van Heerde, WL,
Atiq, F,
Leebeek, FWG,
Schoormans, SCM,
Maas, DPMSM
|
J Thromb Haemost |
2022 |